Press releaseGlobe Newswire
Dogwood Therapeutics
DWTX · NASDAQ
$1.15−$0.06 (−4.96%)TodayMarket closed ·
Prev close $1.21
Latest news
- Press releaseGlobe Newswire
Dogwood to Participate in the 2026 Maxim Growth Summit
- Press releaseGlobe Newswire
Dogwood Announces Completion of Enrollment in Ongoing Halneuron® Phase 2b Trial
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- Press releaseGlobe Newswire
Dogwood Therapeutics Announces Second Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Dogwood Enrolls First 200 Patients in Ongoing Halneuron® Phase 2b Chemotherapy Induced Neuropathy Trial; Top-line Data Expected in Fall 2026
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseGlobe Newswire
Dogwood Therapeutics Announces First Quarter 2026 Financial Results
- News
Earnings Scheduled For May 14, 2026
- News
Dogwood Therapeutics Partners With PRIDCor Therapeutics To Advance Its Anti-Viral Candidates IMC-1 And IMC-2
- Press releaseGlobe Newswire
Dogwood Therapeutics Announces Worldwide Development and Commercialization Partnership for Anti-Viral Assets with Potential Value up to $100M
- News
Dogwood Therapeutics Announces FDA Acceptance Of IND Application For Development Candidate SP16, Administered IV, For Treatment Of Chemotherapy-Induced Pain And Peripheral Neuropathy
- Press releaseGlobe Newswire
Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Press releaseGlobe Newswire
Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
- Press releaseGlobe Newswire
Dogwood Therapeutics Reports Third Quarter 2025 Financial Results
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
Market-Moving News for September 29th
- Press releaseGlobe Newswire
Dogwood Therapeutics Reports Second Quarter 2025 Financial Results
- Press releaseGlobe Newswire
Dogwood Therapeutics Announces First Quarter 2025 Financial Results
- NewsAvi Kapoor
Nasdaq Tumbles Over 400 Points; Netflix Posts Upbeat Earnings
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Press releaseGlobe Newswire
Dogwood Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Why INNOVATE Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- NewsAvi Kapoor
Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.